Announcement • Sep 08

BlinkLab Limited Announces Board Changes

BlinkLab Limited announced that Dr Raphael Bernier, formerly Clinical Lead at Apple Health, was appointed as a Non-Executive Director, effective September 8, 2026. Dr Bernier brings first-hand experience translating clinical science into digital products at global scale, including leading clinical development of Apple’s Mental Wellbeing app for iPhone, iPad and Apple Watch. Dr Bernier is the former Executive Director of the Seattle Children’s Autism Center, one of the autism clinical programs in the United States, and former William J. and Lydia N. Gumerman Endowed Chair in Child Psychiatry at the University of Washington, bringing direct experience of autism clinical care and the diagnostic pathway that BlinkLab Dx1 is designed to support. Dr Bernier has authored more than 200 scientific articles and two books, and has served as principal or co-investigator on more than 40 NIH and foundation-funded studies on the causes and neuroscience of autism and related neurodevelopmental disorders. Dr Bernier recently retired from Apple Health, where he led the clinical development of the Mental Wellbeing app for iPhone, iPad and Apple Watch. He also conducted early-stage research across released and unreleased products in the Apple ecosystem and supported the rollout of additional products relating to child development and cognitive accessibility. He is now a faculty member in the Department of Psychology at the University of Washington and remains an active clinician. Before joining Apple, Dr Bernier held the William J. and Lydia N. Gumerman Endowed Chair in Child Psychiatry at the University of Washington and served as Executive Director of the Seattle Children’s Autism Center, serving thousands of patients each year, and as Associate Director of the University of Washington Center on Human Development and Disability. Dr Bernier has authored more than 200 scientific articles and two books, has been cited over 36,000 times, and has been principal or co-investigator on more than 40 studies funded by the U.S. National Institutes of Health and foundations, focused on the causes and neuroscience of neurodevelopmental disorders. He received his PhD from the University of Washington, completed clinical training at UCLA, and also holds degrees from the University of Wisconsin and Tufts University. BlinkLab Limited also announced that Dr Richard Hopkins has stepped down as Non-Executive Director after serving on the Board since May 2022.

BlinkLab Limited Stock Price

BB1 Share Price Performance

BB1 Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

BlinkLab Limited Key Details

About BB1

Recent BB1 News & Updates

BlinkLab Limited Announces Board Changes

New major risk - Revenue and earnings growth

BlinkLab Limited, Annual General Meeting, Sep 07, 2026

Recent updates

BlinkLab Limited Competitors

Healius

Monash IVF Group

EBR Systems

Paragon Care